A couple of legal developments being reported about Medtronic in the last 12 hours:
The Wall Street Journal reports that the Fridley medical-device maker is moving to report a patient death to the FDA, three months after a woman died following surgery with one of its spine products. Medical-device companies are required to report “adverse events” they learn about in patients with their products. Medtronic said it only recently learned in a lawsuit of the woman’s death.
And the Star Tribune’s Janet Moore reports on a federal whistleblower lawsuit that alleges Medtronic “induced” doctors to use its Infuse bone-graft product in ways not approved by the FDA. Documents filed in the case “hint at the lucrative financial relationship” between Medtronic and several doctors at Twin Cities Spine Center.